Michael R. Wierzbicki

1.5k total citations · 1 hit paper
19 papers, 879 citations indexed

About

Michael R. Wierzbicki is a scholar working on Epidemiology, Microbiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael R. Wierzbicki has authored 19 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Microbiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael R. Wierzbicki's work include Reproductive tract infections research (8 papers), Syphilis Diagnosis and Treatment (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Michael R. Wierzbicki is often cited by papers focused on Reproductive tract infections research (8 papers), Syphilis Diagnosis and Treatment (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Michael R. Wierzbicki collaborates with scholars based in United States, Canada and Japan. Michael R. Wierzbicki's co-authors include Kevin G. Lynch, Jonathan Powell, Sheldon Morris, Kyle M. Kampman, Charles P. O’Brien, Helen M. Pettinati, Audrey L. French, Kelly Anne Spratt, Jeanne Marrazzo and Craig R. Cohen and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Statistical Association and Clinical Infectious Diseases.

In The Last Decade

Michael R. Wierzbicki

19 papers receiving 864 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

2020 218 citations Craig R. Cohen, Michael R. Wierzbicki et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Wierzbicki United States	12	453	379	177	135	135	19	879
Carolyn Johnson United States	12	204 0.5×	428 1.1×	71 0.4×	43 0.3×	85 0.6×	27	872
Matthew Morris United States	14	92 0.2×	236 0.6×	71 0.4×	163 1.2×	24 0.2×	32	925
Steven Specter United States	21	80 0.2×	376 1.0×	76 0.4×	174 1.3×	72 0.5×	70	1.3k
Ede Nagy Germany	16	60 0.1×	141 0.4×	68 0.4×	171 1.3×	97 0.7×	55	791
Chi‐Jen Lee United States	16	183 0.4×	343 0.9×	168 0.9×	175 1.3×	13 0.1×	44	906
Ryan K. Cheu United States	7	190 0.4×	131 0.3×	37 0.2×	130 1.0×	76 0.6×	8	468
Melissa Lewis Canada	9	497 1.1×	712 1.9×	23 0.1×	80 0.6×	34 0.3×	13	1.2k
José G. Castro United States	13	64 0.1×	256 0.7×	48 0.3×	27 0.2×	88 0.7×	45	632
Michael Cooperstock United States	19	57 0.1×	256 0.7×	37 0.2×	117 0.9×	35 0.3×	45	1.2k
Allen McCutchan United States	17	39 0.1×	348 0.9×	85 0.5×	105 0.8×	248 1.8×	27	1.2k

Countries citing papers authored by Michael R. Wierzbicki

Since Specialization

Citations

This map shows the geographic impact of Michael R. Wierzbicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Wierzbicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Wierzbicki more than expected).

Fields of papers citing papers by Michael R. Wierzbicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Wierzbicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Wierzbicki. The network helps show where Michael R. Wierzbicki may publish in the future.

Co-authorship network of co-authors of Michael R. Wierzbicki

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Wierzbicki. A scholar is included among the top collaborators of Michael R. Wierzbicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Wierzbicki. Michael R. Wierzbicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hemmerling, Anke, et al.. (2024). Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease. Sexually Transmitted Diseases. 51(6). 437–440. 6 indexed citations

Dombrowski, Julia C., Michael R. Wierzbicki, Lori M. Newman, et al.. (2021). Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial. Clinical Infectious Diseases. 73(5). 824–831. 46 indexed citations

Cohen, Craig R., Michael R. Wierzbicki, Audrey L. French, et al.. (2020). Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. Obstetrical & Gynecological Survey. 75(10). 601–602. 1 indexed citations

Morris, Sheldon, Claire Bristow, Michael R. Wierzbicki, et al.. (2020). Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. The Lancet Infectious Diseases. 21(5). 668–676. 65 indexed citations

Cohen, Craig R., Michael R. Wierzbicki, Audrey L. French, et al.. (2020). Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine. 382(20). 1906–1915. 218 indexed citations breakdown →

Klausner, Jeffrey D., Claire Bristow, Olusegun O. Soge, et al.. (2020). Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study. Clinical Infectious Diseases. 73(2). 298–303. 32 indexed citations

Woods, Christopher W., Ana M. Sánchez, Geeta K. Swamy, et al.. (2019). An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults. Vaccine. 37(30). 4222–4230. 19 indexed citations

Taylor, Stephanie N., Jeanne Marrazzo, Byron E. Batteiger, et al.. (2018). Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea. New England Journal of Medicine. 379(19). 1835–1845. 149 indexed citations

Miller, Geraldine G., Heidi Schaefer, Sandra Yoder, et al.. (2018). A randomized, placebo‐controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end‐stage renal disease immunized prior to renal transplantation. Transplant Infectious Disease. 20(3). e12874–e12874. 14 indexed citations

10.

Marrazzo, Jeanne, Julia C. Dombrowski, Michael R. Wierzbicki, et al.. (2018). Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial. Clinical Infectious Diseases. 68(5). 803–809. 56 indexed citations

11.

Williams, Christopher S., Mark C. Spitz, John Foley, et al.. (2017). Baseline EEG abnormalities in mild traumatic brain injury from the BIMA study.. PubMed. 43(5). 521–530. 4 indexed citations

12.

Long, Jill, Michael R. Wierzbicki, & Edward W. Hook. (2017). Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment. Sexually Transmitted Diseases. 44(6). 362–364. 1 indexed citations

13.

Matsui, Mié, Chiaki Tanaka, Lisha Niu, et al.. (2016). Age-related Volumetric Changes of Prefrontal Gray and White Matter from Healthy Infancy to Adulthood. 4(1). 1–8. 4 indexed citations

14.

Kampman, Kyle M., Kevin G. Lynch, Helen M. Pettinati, et al.. (2015). A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug and Alcohol Dependence. 155. 105–110. 62 indexed citations

15.

Pettinati, Helen M., Kyle M. Kampman, Kevin G. Lynch, et al.. (2014). A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence. American Journal on Addictions. 23(6). 591–597. 14 indexed citations

16.

Bilker, Warren B., Michael R. Wierzbicki, Colleen Brensinger, Raquel E. Gur, & Ruben C. Gur. (2014). Development of Abbreviated Eight-Item Form of the Penn Verbal Reasoning Test. Assessment. 21(6). 669–678. 9 indexed citations

17.

Kampman, Kyle M., Helen M. Pettinati, Kevin G. Lynch, et al.. (2013). A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug and Alcohol Dependence. 133(1). 94–99. 77 indexed citations

18.

Wierzbicki, Michael R., et al.. (2013). Sparse Semiparametric Nonlinear Model With Application to Chromatographic Fingerprints. Journal of the American Statistical Association. 109(508). 1339–1349. 1 indexed citations

19.

Oslin, David W., Kevin G. Lynch, Stephen A. Maisto, et al.. (2013). A Randomized Clinical Trial of Alcohol Care Management Delivered in Department of Veterans Affairs Primary Care Clinics Versus Specialty Addiction Treatment. Journal of General Internal Medicine. 29(1). 162–168. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact